U.S. flag

An official website of the United States government

NM_004004.6(GJB2):c.514T>A (p.Trp172Arg) AND not provided

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Nov 5, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001861830.6

Allele description [Variation Report for NM_004004.6(GJB2):c.514T>A (p.Trp172Arg)]

NM_004004.6(GJB2):c.514T>A (p.Trp172Arg)

Gene:
GJB2:gap junction protein beta 2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
13q12.11
Genomic location:
Preferred name:
NM_004004.6(GJB2):c.514T>A (p.Trp172Arg)
HGVS:
  • NC_000013.11:g.20189068A>T
  • NG_008358.1:g.8908T>A
  • NM_004004.6:c.514T>AMANE SELECT
  • NP_003995.2:p.Trp172Arg
  • LRG_1350t1:c.514T>A
  • LRG_1350:g.8908T>A
  • LRG_1350p1:p.Trp172Arg
  • NC_000013.10:g.20763207A>T
  • NM_004004.5:c.514T>A
Protein change:
W172R
Links:
dbSNP: rs770330002
NCBI 1000 Genomes Browser:
rs770330002
Molecular consequence:
  • NM_004004.6:c.514T>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002246561Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Nov 5, 2023)
germlineclinical testing

PubMed (5)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Functional consequences of novel connexin 26 mutations associated with hereditary hearing loss.

Mani RS, Ganapathy A, Jalvi R, Srikumari Srisailapathy CR, Malhotra V, Chadha S, Agarwal A, Ramesh A, Rangasayee RR, Anand A.

Eur J Hum Genet. 2009 Apr;17(4):502-9. doi: 10.1038/ejhg.2008.179. Epub 2008 Oct 22.

PubMed [citation]
PMID:
18941476
PMCID:
PMC2986212

First molecular screening of deafness in the Altai Republic population.

Posukh O, Pallares-Ruiz N, Tadinova V, Osipova L, Claustres M, Roux AF.

BMC Med Genet. 2005 Mar 24;6:12.

PubMed [citation]
PMID:
15790391
PMCID:
PMC1079841
See all PubMed Citations (5)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV002246561.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (5)

Description

This sequence change replaces tryptophan, which is neutral and slightly polar, with arginine, which is basic and polar, at codon 172 of the GJB2 protein (p.Trp172Arg). This variant is present in population databases (rs770330002, gnomAD 0.02%). This missense change has been observed in individuals with autosomal recessive non-syndromic deafness (PMID: 18941476). ClinVar contains an entry for this variant (Variation ID: 557805). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on GJB2 protein function. Experimental studies have shown that this missense change affects GJB2 function (PMID: 18941476). This variant disrupts the p.Trp172 amino acid residue in GJB2. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 15790391, 20201936, 31195736). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024